Chow KU - Search Results

1

Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas.

Rummel MJ, Chow KU, Jäger E, Leimer L, Hossfeld DK, Bergmann L, Peters HD, Hansmann ML, Meyer A, Hoelzer D, Mitrou PS. Rummel MJ, et al. Among authors: chow ku. Leuk Lymphoma. 1999 Sep;35(1-2):129-38. doi: 10.3109/10428199909145712. Leuk Lymphoma. 1999. PMID: 10512170 Clinical Trial.

2

Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells.

Chow KU, Boehrer S, Bojunga J, Stieler M, Rummel MJ, Fauth F, Schneider B, Martin H, Hoelzer D, Weidmann E, Mitrou PS. Chow KU, et al. Leuk Lymphoma. 2002 Feb;43(2):377-84. doi: 10.1080/10428190290006198. Leuk Lymphoma. 2002. PMID: 11999573

3

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.

Rummel MJ, Al-Batran SE, Kim SZ, Welslau M, Hecker R, Kofahl-Krause D, Josten KM, Dürk H, Rost A, Neise M, von Grünhagen U, Chow KU, Hansmann ML, Hoelzer D, Mitrou PS. Rummel MJ, et al. Among authors: chow ku. J Clin Oncol. 2005 May 20;23(15):3383-9. doi: 10.1200/JCO.2005.08.100. J Clin Oncol. 2005. PMID: 15908650 Clinical Trial.

4

Dexa-BEAM as salvage therapy in patients with primary refractory aggressive non-Hodgkin lymphoma.

Atta J, Chow KU, Weidmann E, Mitrou PS, Hoelzer D, Martin H. Atta J, et al. Among authors: chow ku. Leuk Lymphoma. 2007 Feb;48(2):349-56. doi: 10.1080/10428190600880084. Leuk Lymphoma. 2007. PMID: 17325896

5

A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.

Weidmann E, Hess G, Chow KU, Krause SW, Subklewe M, Kruse J, Weisel KC, Soekler M, Kim SZ, Napieralski S, Rech J, Dreyling M, Jäger E, Mitrou PS. Weidmann E, et al. Among authors: chow ku. Leuk Lymphoma. 2010 Mar;51(3):447-55. doi: 10.3109/10428190903580402. Leuk Lymphoma. 2010. PMID: 20141439 Clinical Trial.

6

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse.

Rummel MJ, Chow KU, Jäger E, Hossfeld DK, Bergmann L, Peters HD, Hansmann ML, Meyer A, Hoelzer D, Mitrou PS. Rummel MJ, et al. Among authors: chow ku. Ann Oncol. 1999 Jan;10(1):115-7. doi: 10.1023/a:1008325212484. Ann Oncol. 1999. PMID: 10076731 Free article. Clinical Trial.

7

Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease.

Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, Hör G, Hoelzer D, Mitrou PS. Wiedmann E, et al. Among authors: chow ku. Leuk Lymphoma. 1999 Aug;34(5-6):545-51. doi: 10.3109/10428199909058482. Leuk Lymphoma. 1999. PMID: 10492078 Clinical Trial.

8

Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone.

Chow KU, Rummel MJ, Weidmann E, Ries J, Jantschke P, Boehrer S, Pourebrahim F, Napieralski S, Stein J, Martin H, Hoelzer D, Mitrou PS. Chow KU, et al. Leuk Lymphoma. 2000 Feb;36(5-6):559-67. doi: 10.3109/10428190009148404. Leuk Lymphoma. 2000. PMID: 10784401

9

Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).

Chow KU, Mitrou PS, Geduldig K, Helm EB, Hoelzer D, Brodt HR. Chow KU, et al. Leuk Lymphoma. 2001 Mar;41(1-2):105-16. doi: 10.3109/10428190109057959. Leuk Lymphoma. 2001. PMID: 11342362

10

Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma.

Rummel MJ, Chow KU, Karakas T, Jäger E, Mezger J, von Grünhagen U, Schalk KP, Burkhard O, Hansmann ML, Ritzel H, Bergmann L, Hoelzer D, Mitrou PS. Rummel MJ, et al. Among authors: chow ku. Eur J Cancer. 2002 Sep;38(13):1739-46. doi: 10.1016/s0959-8049(02)00143-0. Eur J Cancer. 2002. PMID: 12175690 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters